These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33096860)

  • 1. The Function and Mechanism of Lipid Molecules and Their Roles in The Diagnosis and Prognosis of Breast Cancer.
    Guo R; Chen Y; Borgard H; Jijiwa M; Nasu M; He M; Deng Y
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.
    Ward AV; Anderson SM; Sartorius CA
    J Mammary Gland Biol Neoplasia; 2021 Dec; 26(4):399-417. PubMed ID: 34914014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
    Zhang X; Yang H
    Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.
    Yang Q; Fu Y; Wang J; Yang H; Zhang X
    J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study.
    Cao B; Yang S; Yan L; Li N
    Cancer Biomark; 2023; 37(4):289-297. PubMed ID: 37302027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of nuclear magnetic resonance in lipid analyses: An emerging powerful tool for lipidomics studies.
    Li J; Vosegaard T; Guo Z
    Prog Lipid Res; 2017 Oct; 68():37-56. PubMed ID: 28911967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Lipidomics in Tumor Diagnosis and Therapy.
    Wang Y
    Adv Exp Med Biol; 2021; 1316():25-39. PubMed ID: 33740241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass spectrometry imaging technology and its application in breast cancer research].
    Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
    Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomics in biomedical research-practical considerations.
    Hyötyläinen T; Ahonen L; Pöhö P; Orešič M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):800-803. PubMed ID: 28408341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid metabolism remodeling: A hurdle in breast cancer therapy.
    Xiao Q; Xia M; Tang W; Zhao H; Chen Y; Zhong J
    Cancer Lett; 2024 Feb; 582():216512. PubMed ID: 38036043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics.
    Dadhich R; Kapoor S
    Mol Cell Biochem; 2022 Nov; 477(11):2507-2528. PubMed ID: 35595957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
    Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
    Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
    J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
    Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
    Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG1 regulates neutral lipid metabolism in breast cancer cells.
    Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
    Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption/ionization mass spectrometry imaging of cell cultures for the lipidomic analysis of potential lipid markers in human breast cancer invasion.
    Wang S; Chen X; Luan H; Gao D; Lin S; Cai Z; Liu J; Liu H; Jiang Y
    Rapid Commun Mass Spectrom; 2016 Feb; 30(4):533-42. PubMed ID: 26777684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in lipidomics for disease research.
    Yang L; Li M; Shan Y; Shen S; Bai Y; Liu H
    J Sep Sci; 2016 Jan; 39(1):38-50. PubMed ID: 26394722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipidomics in assessing the functional lipid composition in breast milk.
    Ganeshalingam M; Enstad S; Sen S; Cheema S; Esposito F; Thomas R
    Front Nutr; 2022; 9():899401. PubMed ID: 36118752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
    Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
    Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.